Genetic Analysis of the Bovine Papillomavirus E2 Transcriptional Activation Domain  by Breiding, David E. et al.
VIROLOGY 221, 34–43 (1996)
ARTICLE NO. 0350
Genetic Analysis of the Bovine Papillomavirus E2 Transcriptional Activation Domain
DAVID E. BREIDING,* MARTHA J. GROSSEL,† and ELLIOT J. ANDROPHY*,†,1
*Department of Dermatology, New England Medical Center and Tufts University School of Medicine, and †Department
of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111
Received February 26, 1996; accepted May 2, 1996
The bovine papillomavirus type 1 E2 transactivator has a large amino-terminal 215-residue transcriptional activation
domain (TAD) that is active in Saccharomyces cerevisiae and higher eukaryotic cells. Comparison to other transcriptional
activators suggests that its functions may be mediated in part through two acidic regions, A1 and A2, in this domain. We
have characterized the functional elements within the E2 TAD using LexA–E2 fusions and by screening randomly generated
libraries of E2 mutations for transcriptional activation in yeast. The A1 region was highly sensitive to substitutions that
reduce negative charge, although there was not a perfect correlation between overall charge and transcriptional activity.
Mutations were isolated within a hydrophobic amino acid motif that overlaps the A2 region and resembles elements
described in other viral and cellular transactivation domains. When fused to the LexA DNA binding domain, this hydrophobic
motif within the acidic A2 region was unable to activate transcription in S. cerevisiae. Multiple highly defective mutations
primarily altering hydrophobic amino acids were identified in the distal third of the E2 TAD. The transcription phenotype of
many of these E2 TAD mutations was similar in yeast and COS cells. q 1996 Academic Press, Inc.
INTRODUCTION ing protein (TBP) (Steger et al., 1995; Rank and Lambert,
1995), TFIIB (Rank and Lambert, 1995), and cellular tran-
The papillomavirus E2 protein is essential for viral scription factors including Sp1 (Li et al., 1991), USF, and
gene expression and replication, processes known to be CTF (Ham et al., 1991; Ushikai et al., 1994). The N-termi-
tightly linked to the differentiation program of the host nal half of the E2 TAD has been proposed to form two
epithelial cell. One model is that E2 acts as an enhancer acidic amphipathic helices (Giri and Yaniv, 1988), a motif
by facilitating the assembly of basal transcription com- common in viral and cellular transcriptional activators.
plexes which subsequently initiate RNA synthesis. The Like many ‘‘acidic’’ activators, E2 transcription functions
bovine papillomavirus type 1 (BPV-1) E2 gene encodes are detectable in Saccharomyces cerevisiae (Lambert et
a 410-amino-acid protein. The N-terminal 215 residues al., 1989; Morrissey et al., 1989; Stanway et al., 1989).
of E2 are required for transcriptional activation and while Transcriptional activation by E2 is abolished by deletion
the functional elements of this region have not been char- of the acidic regions, yet it has not been shown that
acterized, it is presumed to coordinate interactions with the negatively charged amino acids of this region are
cellular factors (Dostatni et al., 1988; Giri and Yaniv, 1988; responsible for an E2 function.
Haugen et al., 1988; McBride et al., 1988, 1989; Moskaluk Genetic analyses of transcriptional activation domains
and Bastia, 1989). The C-terminal 125 amino acids of E2 including those from VP16, RTA, and SP1 have identified
specifically bind the DNA sequence ACCGN4CGGT, an bulky hydrophobic (BH) amino acid motifs which are criti-
element found in close juxtaposition to most papillomavi- cal to function (Cress and Triezenberg, 1991; Hardwick
rus promoters (Androphy et al., 1987a,b; Moskaluk and et al., 1992; Regier et al., 1993; Blair et al., 1994; Gill et
Bastia, 1988) which functions as an E2-dependent en- al., 1994). These motifs are thought to mediate protein –
hancer (Harrison et al., 1987; Haugen et al., 1987; Spal- protein interactions with basal transcription factors such
holz et al., 1987; Hawley-Nelson et al., 1988). as TBP, TFIIB, and TAFs (Gill et al., 1994). Mutation of
The mechanism by which the N-terminal E2 transcrip- individual BH residues at consensus positions in some
tional activation region stimulates gene expression has BH motifs, including F443 of VP16, can result in complete
yet to be resolved. E2 has been demonstrated to cooper- inactivation of transactivation function (Cress and Trie-
atively stimulate transcription in vivo with the TATA bind- zenberg, 1991; Regier et al., 1993). We have noted similar
motifs in the acidic regions of papillomavirus E2 proteins,
but their functional significance is unknown. To identify1 To whom correspondence and reprint requests should be ad-
transcriptionally defective E2 mutants, we performed adressed at Department of Dermatology, New England Medical Center
genetic screen in S. cerevisiae in order to characterizeBox 166, 750 Washington Street, Boston, MA 02111. E-mail: eandroph@
opal.tufts.edu. functional domains and amino acids of its TAD.
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MATERIALS AND METHODS extracts were resolved by polyacrylamide electrophore-
sis and electroblotted to Immobilon P (Millipore), and the
PCR misincorporation mutagenesis was used to cre- presence of full-length E2 was determined by Western
ate three mutant libraries targeting the transcriptional blot with rabbit antiserum to BPV-1 E2 (Androphy et al.,
activation domain of BPV-1 E2 (A: residues 1–71; B: resi- 1987a). Mutants which scored positive for synthesis of
dues 71–134; and C: residues 133–216) (Leung et al., full-length E2 in the Western blot and which failed to
1988). Mutant libraries A and B were generated using transactivate the reporter after repeat testing were char-
primer set M1 (5* CTCGGATCCCATGGAGACAGCATG acterized by DNA sequence analysis with Sequenase 2.0
3*, nt 2608–2623) and M2 (5* GCTGCCAGCCGTCCTC 3*, (U.S. Biochemicals).
nt 3047–3032). The M1/M2 PCR product was gel purified, Fusions of the LexA DNA binding domain to E2 were
cleaved with BamHI/BglI (library A, nt 2608–2815) or BglI/ made using 2m vectors, YEplac181GLexA202 (LEU2) and
AccI (library B, nt 2818–3006), and ligated separately YEplac112GLexA202B (TRP1), in which synthesis of the
to M13mp19E2-286 which was cleaved with the same 202-amino-acid LexA DNA binding domain, obtained from
enzymes. Library C used primers M3 (5* CCAGGGTGG- pEG202 (Gyuris et al., 1993), was galactose inducible from
TAGAGGTG 3*, nt 2952–2956) and M4 (5* CCTTCGCTA- the GAL 1-10 UAS. Transactivation by LexA–E2 fusions
GCGACCCAGACTC 3*, nt 3261–3240). Primer M4 intro- was performed by introducing the fusion into DBY1 along
duces a translationally silent NheI site at nucleotides with the LexA/LacZ reporter pSH18-34 (kindly provided by
3251–3256. The M3/M4 PCR product was cleaved with R. Brent). Mutations of E2 were excised from YEplac112GE2
AccI and NheI and ligated to similarly cleaved pUC19 E2- as SphI/KpnI fragments and transferred to either YEplac18-
286N, which contains the engineered NheI site. Ligation 1GLexAE2-300B (Library C isolates) or YEplac181GLEX-
reactions were introduced into Escherichia coli MV1190 AE2N-300B (library A and B isolates) which contains an
(libraries A and B) or DH5a (library C) by electroporation, NheI site. Mutant LexA fusions were confirmed by gain (for
and recombinant virus or colonies from several plates library A and B isolates) or loss (library C) of the NheI site.
were pooled. Double-stranded replicative form M13mp19 The LexA fusion of the human chaperonin 10 cDNA was
E2 286 DNA (RF DNA) was prepared after infection of transferred from pEG202 to YEplac181GLexA202 (Chen et
MV1190. The mutant RF DNA or plasmid DNA was al., 1994). Plate assays for transcriptional activation were
cleaved with BamHI and KpnI and the E2 1–286 fragment performed as described above for full-length E2 on galac-
was purified and ligated to the YEplac112G-E2 fragment tose/X-gal plates. All deletion mutants of BPV-1 E2 were
encoding E2 amino acids 287–410. YEplac112G, modi- constructed in the YEplac112GE2 vector. The VP16 trans-
fied from YEplac112 (Gietz and Sugino, 1988), includes activation domain (residues 410–490) was transferred to
the GAL 1-10 UAS with the TRP1 gene and 2m yeast YEplac112GE2D54, YEplacc112GE2D139, and YEplac112-
replicon. These ligation reactions were introduced into GE2TR as a BamHI fragment.
DH5a by electroporation and resulted in individual librar- The transactivation potential of defective mutants
ies of approximately 25,000 transformants. was further characterized by quantitative b-galactosi-
E2 mutant libraries were screened in the S. cerevisiae dase assay (Guarente and Mason, 1983). Selected
strain DBY1. This strain was constructed by inactivation mutants were transferred to the expression vector
of the TRP1 gene of BGW17a (MATa, leu2, 2-leu2, -11; pBG331E2TR (Barsoum et al., 1992) as BamHI – KpnI
his4–his519, ade1–-ade100,ura3–ura52) used for previ- fragments generating a full-length E2 with mutation.
ous genetic studies of BPV-1 E2 (Prakash et al., 1992). Mutants were assayed for transcriptional activity in
The TRP1 gene of BGW1-7a was inactivated by one-step COS cells as previously reported (Grossel et al., 1996).
gene replacement (Alani et al., 1987). The YEplac112GE2 Total cell extracts from the electroporated COS cells
mutant library was transformed into DBY1 containing lysed in denaturation buffer were analyzed for E2 pro-
pBsy72 (Morrissey et al., 1989). Transformants were se- teins by immunoblot.
lected on minimal medium (YMM) minus tryptophan and
uracil supplemented with 2% glucose and subsequently RESULTS
replica plated to galactose/X-gal media (Prakash et al.,
The transcriptional activation domain (TAD) of BPV-11992). After 48 hr at 307 white and light blue colonies on
the galactose plate were selected from the correspond- E2 has been previously described to encompass amino
ing YMM/glucose plate. Putative mutant E2 plasmids acids 1–220 (McBride et al., 1989). Prior to undertaking
were then recovered from these cells by transformation an extensive screen for point mutations in this domain,
of total DNA extracts into DH5a and reintroduced into we attempted to precisely delineate the limits of the E2
DBY1 carrying pBsy 72 to confirm the transactivation phe- TAD in the yeast model. Deletion of the 15 amino-terminal
notype (Ausbel et al., 1993). For immunoblots, the cells residues of E2, with initiation at methionine 16, reduced
were cultured in YMM with galactose for 12 hr, pelleted, transcriptional activation to background of the empty vec-
tor (Fig. 1A), as previously described (McBride et al.,and resuspended in 21 SDS/PAGE sample buffer. Yeast
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FIG. 1. (A) Transcriptional activation by BPV E2 deletion mutants in S. cerevisiae. E2 deletion mutants in YEplac112G were introduced in strain
DBY1 along with E2 responsive LacZ reporter pBsy72. Four colonies for each mutant were transferred to galactose/X-gal minus tryptophan and
uracil plates to induce E2 synthesis, and colony colors were scored at 24 and 48 hr (0 indicates white; / indicates intensity of blue color). (B)
Induction of LacZ activity of the LexA responsive promoter by LexA DNA binding domain fusions to regions of BPV-1 E2. The LexA–E2 chimeras
were introduced into DBY1 along with the LexA responsive LacZ reporter pSH18-34. Four colonies for each construct were transferred to galactose/
X-gal minus leucine and uracil plates and their color were scored at 24 and 48 hr (0 indicates white; / indicates intensity of blue color).
1989). Truncated E2 proteins lacking amino acids 1–54 including amino acids 310 – 410 binds the Pol II tran-
scription factors TBP and TFIIB (Rank and Lambert,(D54), 1–74 (D74), 1–113 (D113), and 1–139 (D139)
were completely defective for transcriptional activation. 1995). The functional significance of the interactions
between TBP and TFIIB with the E2 DNA binding/di-Fusion of the VP16 TAD (residues 410–490) to the E2D54
and E2D113 deletions resulted in potent activators which merization domain remains to be determined. We have
also detected binding of the E2 C-terminus to thesestrongly induced the E2-dependent reporter as efficiently
as VP16:E2TR (residues 162–410) (Lamberti et al., 1990). basal factors (J.-M. Yao, D. Breiding, and E. Androphy,
unpublished data). Mutations in this region of E2 thatThese results indicate that the transcription defect of
these N-terminal deletion mutants is a result of inactiva- are transcriptionally defective in mammalian cells and
retain dimerization and site-specific DNA binding havetion of the E2 TAD and imply that the C-terminal DNA
binding domain functions were not abrogated by these been described (Grossel et al., 1996). To determine
if the E2 transcriptional activation domain is able toperturbations. Internal in-frame deletions of amino acids
55–215 and 139–215 also completely abolished tran- function independently of the C-terminal DNA binding
scriptional activation. However, the 215–286 deletion, domain, the LexA DNA binding domain was fused to
which removes the ‘‘hinge region’’ of E2, was able to a similar set of E2 TAD deletions (Fig. 1B). Fusions
activate transcription, although not as efficiently as WT containing the N-terminal 300, 284, and 216 residues
E2, as has been previously reported (Winokur and activated the LexA-dependent LacZ reporter, while
McBride, 1992). Together, the phenotype of these mu- yeast expressing LexA202 and a fusion of LexA to hu-
tants suggests that the BPV-1 E2 TAD comprises amino man chaperonin 10 (LexA – SD22) remained white (data
acids 1–215. not shown). LexA – E2 1 – 54, LexA – E2 1 – 91, LexA – E2
1 – 113, LexA – E2 1 – 133, and LexA – E2 1 – 162 includeIt has been recently reported that the E2 C-terminus
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FIG. 1—Continued
the acidic regions of the E2 TAD and showed no tran- to identify mutants which have a 50% or greater reduction
in b-galactosidase activity. In some cases mutants werescriptional activity in this assay. Surprisingly, LexA –
E2 113 – 216 and LexA – E2 133 – 216 weakly stimulated obtained by direct sequence analysis of individual colo-
nies from the bacterial plasmid library. These isolatesthe LexA reporter. These LexA fusions possessed two-
to threefold less activity than LexA – E2 1 – 216, indicat- were also subjected to immunoblot analysis to confirm
the presence of E2. As expected, in addition to pointing the requirement for amino-terminal residues for full
activity. mutations, each misincorporation library yielded at least
40 isolates with two or more mutations. CharacterizationTaken together these experiments demonstrate that
E2 TAD is able to function independently of the C-termi- of mutants obtained by phenotypic screening, when com-
pared with those identified from library A by direct se-nus of E2 in yeast and that full activity of this domain
requires residues 1 to 215. To identify amino acids in quence analysis, indicated that this screen identified
substitutions at residues critical for transcriptional activa-this domain necessary for transcriptional activation, we
used a random mutagenesis scheme followed by pheno- tion from a random pool of mutations. Seven single-hit
mutations identified by direct sequence analysistypic selection in yeast to isolate defective point mutants.
Three libraries spanning residues 1–71, 71–134, and spanned residues 23 and 62, and with the exception of
L54P (14% WT E2) all retain at least 40% or more of WT134–215, designated A, B, and C, respectively, were gen-
erated by polymerase chain misincorporation mutagene- activity (Table 1, Figure 2). Seven highly defective point
mutants (less than 2% of WT activity) were isolated insis (Leung et al., 1988). These were introduced into the
context of full-length BPV-1 E2 in the yeast expression the phenotypic screen and six fall between residues 14
and 40 (Table 1). The seventh, Q66R, is near a cluster ofvector YEplac112GE2. The libraries were transformed
into DBY1 carrying an E2-dependent LacZ reporter highly defective mutations obtained from library B (resi-
dues 71–134). Mutants from library B are highly defec-pBsy72. Colonies were screened by replica plating to
media containing galactose to induce E2 synthesis. Total tive, and substitutions fall between amino acids 86 and
107. Screening of library C yielded six transactivationcell protein extracts from white and light blue colonies
were examined for the presence of full-length E2 by im- defective mutants of which three, Y138H, W145R, and
R208G, possessed 8% or less of wild-type E2 activity.munoblot to eliminate mutations which introduce termi-
nation codons or frameshifts. Plasmids carrying the E2 Point mutants which exhibit a severe transcriptional
activation defect were chosen from each library and as-mutation were isolated, transformed into fresh yeast, and
tested on galactose/X-gal plates. Those which retained sayed for transcriptional activation in S. cerevisiae as
fusions of the LexA DNA binding domain to E2 residuesthe defective phenotype were further characterized by
quantitative b-galactosidase assay and DNA sequence 1–300. Since this fusion lacks the C-terminal E2 DNA
binding and dimerization domain, it might distinguish mu-analysis. Through this phenotypic screen it was possible
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TABLE 1
Transcriptional Activation by BPV-1 E2 Mutants in S. cerevisiae
% wild-type
Mutant activity
Library A residues 1–71 Q 15 H 1
S 23 G 1
D 24 Aa 75
K 25 Ea 76
H 29 R 1
A1 amino acids 1–40; net negative charge 03I 30 Ma 42
L 31 P 1
L 31 Q 18
Y 32 H 1
E 39 G 1
A 46 Ea 88
V 53 Aa 82
L 54 Pa 14
C 57 R 23
H 61 Ra 53
Q 66 R 1
Library B residues 71–133 F 87 S 1 A2 amino acids 65–90; net negative charge 02
W 92 R 1
S 93 P 1
W 99 C 1
E 105 G 13
P 106 S 1
N127 Y 14
W 130 R 16
Library C residues 134–216 Y 138 F 23
Y 138 H 1
W 145 R 1
E 176 G 23
R 179 G 17
S 181 F 16
R 208 G 8
a Mutants identified by direct DNA sequence analysis of isolates from misincorporation library.
tations within the E2 N-terminus which disrupt function from libraries A (Q15H, E39G), B (F87S, W92R, and
W99C), and C (Y138H, W145R) were found to be similarlyof the C-terminal E2 domain. All E2 mutants which were
highly defective for transactivation (less than 2% WT E2) defective in COS cells and yeast. This suggests that the
three clusters of defective mutants which span residueswere similarly defective when assayed as LexA fusions
(Table 2). One mutant (N127Y, 14% of WT E2) appeared 15–39, 66–106, and 138–145 represent interdependent
functional domains required for transcriptional activationto transactivate as well or better than wild type when
tested as a LexA fusion. These results suggest that with in both yeast and mammalian cells. Western blots
showed that these mutant proteins were expressed, al-the exception of N127Y, all mutant phenotypes can be
attributed to specific inactivation of the E2 transcriptional though some, including D24A, K25E, F87S, W99C, and
W145R, were at levels less that WT E2 (Fig. 3). However,activation domain.
Selected mutants from each misincorporation library this reduction in protein level does not account for their
transcriptional defect. For example, while the amount ofwhich are highly defective in yeast were further charac-
terized for transcriptional activation in COS-7 cells (Table D24A protein present was very low, it demonstrated 36%
of WT activity. In contrast, mutant proteins such as F87S,3). The transcriptional activation phenotype of these mu-
tants in mammalian cells parallels the results in yeast W99C, and W145R were expressed at higher levels than
D24A yet were highly defective for transcriptional activa-and indicates that the yeast phenotypic screen identified
residues critical to E2 function. Highly defective mutants tion.
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FIG. 2. Alignment of bulky hydrophobic residues in the E2 and other transcriptional activation domains. (A) Alignment of bulky hydrophobic
residues in transactivation domains of VP16, GAL4, RTA, and Sp1 (Cress and Triezenberg, 1991; Hardwick et al., 1992; Regier et al., 1993; Blair et
al., 1994; Gill et al., 1994) with motifs in BPV-1 and HPV-11, -16, and -18 E2. (B) Transactivation defective mutations in this interval of BPV-1 E2 are
shown along with the bulky hydrophobic motif. Below each amino acid substitution the transactivation phenotype in S. cerevisiae is listed as
percentage of wild-type BPV-1 E2 activity. (C) Same as for B, except that the motif and mutations span the 87 to 106 interval of BPV-1 E2.
DISCUSSION Fourteen point mutations isolated by phenotypic
screening demonstrated complete loss of E2 transcrip-Early studies have shown that the amino-terminal 215
tional activation. The fact that we could isolate singleamino acids of the BPV-1 E2 protein are necessary for
amino acid changes that were severely crippled for tran-transcriptional activation (McBride et al., 1989); however,
scriptional activation was not predictable. Two lines oflittle is known of the structural and functional organiza-
evidence suggest that most of the highly defective muta-tion of the E2 transcriptional activation domain. While this
tions affect a specific function of the E2 TAD. First, all 14article was in preparation, point mutations were reported
were totally defective for transactivation when assayed inwhich examine the role of the BPV-1 and HPV-16 E2
the context of LexA DNA binding domain fusion to theTADs in viral DNA transcription and replication (Brokaw
E2 TAD (amino acids 1–300) into which the mutationset al., 1996; Sakai et al., 1996). From this study it is clear
were transferred (Table 2). Second, all mutant E2 proteinsthat many conserved residues throughout the E2 TAD
except W92R and P106S were able to interact with BPV-are necessary for transcriptional activation. We chose to
1 E1 in a two-hybrid assay, indicating that this E2 TADisolate transactivation defective point mutations in this
function is preserved (N. Moscufo, D. Breiding, and E.domain using a functional screen in S. cerevisiae, a
Androphy, unpublished data). The phenotype of P106Smodel previously used to characterize the E2 C-terminal
may be caused by a nuclear localization defect, sinceDNA binding and dimerization domain (Prakash et al.,
another substitution of this residue has been reported1992). Libraries of random mutations in the E2 gene were
to be defective for this function (Brokaw et al., 1996;screened for inability to activate an E2-dependent pro-
Skiadopoulos and McBride, 1996).moter. It is probable that these E2 mutants will include
Early genetic analysis of the VP16 and GAL4 transac-proteins that would be misfolded, unstable, or unable to
tion domains indicated a correlation between overall netbind cellular factors necessary for the E2 transcription
or processing pathways. negative charge and transcriptional activity (Gill and
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TABLE 2 bert et al., 1989; McBride et al., 1989). However, unlike
the VP16 TAD, these regions of E2 did not possess inde-Transactivation in S. cerevisiae by E2 TAD Mutants
pendent transcriptional activity when assayed in the con-in LexA –E2 Fusions
text of LexA fusions in yeast, or with internal deletions
Wild type /// which retain the E2 DNA binding domain (Fig. 1B) (Lam-
Q 15 H 0 bert et al., 1989). Similar in-frame deletions which retain
S 23 G //0
regions A1 and A2 were also unable to activate transcrip-H 29 R 0
tion in mammalian cells (Giri and Yaniv, 1988; HaugenL 31 P 0
E 39 G 0 et al., 1988; McBride et al., 1989).
L 54 P / Two clusters of highly defective point mutations iso-
Q 66 R 0 lated in this phenotypic screen fall in regions A1 and A2.
F 87 S 0
Mutations which reduce the net negative charge of theW 92 R 0
A1 (Q15H, Y32H, and E39G) and A2 (Q66R) regions es-W 99 C 0
E 105 G //0 sentially abolished transcriptional activation in both
P 106 S 0 yeast and mammalian cells. One exception, D24A, re-
N 127 Y /// tained significant activity in yeast (75% of WT) and COS-
W 130 R 0
7 cells (57% of WT). These results contrast with the ef-Y 138 H 0
fects of point mutations in the VP16 and GAL4 activationW 145 R 0
E 176 G / domains. These E2 mutations were less conservative
R 179 G / than the engineered aspartic acid to asparagine substitu-
S 181 F / tions used to analyze the role of charge in VP16 function,
R 208 G 0
and this may contribute to the severity of some E2 mutant
phenotypes. Radical changes at individual acidic posi-Note. E2 mutations were transferred to the galactose inducible LexA
fusion vector YEplac181GLexAE2-300 and transformed into yeast strain tions of GAL4 activation domain I did not severely com-
DBY1 containing the LexA/LacZ reporter pSH18-34. For each mutant 4 promise function (Gill and Ptashne, 1987). It has been
colonies were innoculated on galactose/x-gal plates and scored for recently reported that E39D, which does not affect the
blue color formation at 24 and 48 hr (0 indicates white and/ indicates
charge of region A1, unlike E39G described in this study,intensity of blue color).
is similarly defective for transactivation (Brokaw et al.,
1996). This suggests that the substitutions of specific
amino acids, independent of charge, alter E2 functionPtashne, 1987; Cress and Triezenberg, 1991). Substitu-
tion of individual acidic residues in these activation do- and could be responsible for the defective phenotypes
of some mutants reported here. Furthermore, the pheno-mains reduced transactivation, but did not result in a
highly defective phenotype. Dramatic reductions in the type of K25E, which increases the negative charge of
amino acids 1–40 from03 to05, indicates that E2 trans-activity of VP16 (10% or less of wild type) could only
be achieved by combination of several mutations which activation is not directly proportional to its net charge.
reduced the net negative charge from 08 to 02 (Cress
and Triezenberg, 1991). Activity of the cryptic N-terminal
TABLE 3GAL4 activation domain I showed a similar dependence
on charge, suggesting that a charge threshold may influ- Transcriptional Activation by BPV1 E2 Mutants in COS-7 Cells
ence the function of acidic activation domains (Gill and
Construct % wild-type activityPtashne, 1987). Mutation of acidic residues in the C-
terminal TAD of GAL4 (amino acids 854–874) revealed
Wild type 100
an imperfect correlation between negative charge and Q 15 H 3
activation; however, uncharged or positively charged D 24 A 36
K 25 E 77substitutions activated to near wild-type levels (Leuther
E 39 G 3et al., 1993). Whether negatively charged amino acids
F 87 S 3are relevant for function of acidic activators has been
W 92 R 2
questioned (Hahn, 1993). W 99 C 3
The E2 transcriptional activation domain contains two N 127 Y 44
Y 138 H 9regions of potential acidic amphipathic helical conforma-
W 145 R 1tion (Giri and Yaniv, 1988) , A1 (amino acids 1–50) and
A2 (amino acids 65–90). Residues 1–40 of A1 possess
Note. Trans-activation by wild-type E2 and E2 mutants in COS-7
a net charge of 03 and A2 has a net charge 02. Deletion cells. Plasmid pBG331 carrying wt E2, mutant, or vector alone were
of either motif abolishes E2-stimulated transcription in electroporated into COS-7 cells with an E2-dependent growth hormone
(hGH) reporter and media were assayed for hGH.yeast and mammalian cells (Giri and Yaniv, 1988; Lam-
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FIG. 3. Immunoblot of wild-type and E2 mutant proteins expressed in COS-7 cells.
Mutations which increased the acidity of the GAL4 activa- tif (S93P, E105G, and P106S). This correlation implies
that the 87–107 interval of E2 defines a functional activa-tion domain I resulted in greater activity than wild type
(Gill and Ptashne, 1987; Gill et al., 1990), while E2 K25E tion unit and is thus similar to the VP16 A and RTA do-
mains. As with BH consensus positions in VP16 A (Regierhad only 75% of wild-type activity in yeast and mamma-
lian cells. In addition, our phenotypic screen has identi- et al., 1993), transactivation by E2 is only partially im-
paired by substitution of tryptophan 92 with another BHfied two transcriptionally defective mutations, S23G and
L31P, which do not affect the charge of region A1. residue, phenylalanine (Brokaw et al., 1996). Unlike VP16
A, this E2 motif does not lie entirely within a region ofRegions A1 and A2 of BPV-1 E2 were examined for
the pattern of BH amino acids, as these have been shown net negative charge, only partially overlapping with the
A2 interval (residues 64 to 94). In addition, while muta-to form important motifs in both acidic and positively
charged transcriptional activators (Cress and Triezen- tional analysis shows that this motif is critical to E2 func-
tion, it does not activate transcription independently inberg, 1991; Hardwick et al., 1992; Regier et al., 1993; Gill
et al., 1994). As with the other activation domains, more yeast (Fig. 1). Differences between the VP16 A and B
domains have been described at the level of protein –than one alignment of BH residues can be made (Hard-
wick et al., 1992). Figure 2A shows the alignment max- protein interaction: while VP16 B associates with the
TAFII40 component of TFIID in vitro, VP16 A does notimizing the number of BH residues at consensus posi-
tions. Four BH residues in the region A1 motif (residues (Goodrich et al., 1993).
Our genetic studies indicate that a function essential26 to 49) fall at consensus positions. However, only one
mutation affecting a BH consensus position, L31P, was to transcriptional activation by E2 in yeast and mamma-
lian cells lies between residues 127 and 209 (Tables 1identified by phenotypic screening and showed less than
1% of WT activity in yeast and COS cells (Fig. 2C). A and 2). Consistent with this analysis, E2 residues 134 to
216 possess the ability to activate transcription in yeastsecond substitution at this residue, L31Q isolated by di-
rect sequence analysis of library isolates, also displayed when fused to the LexA DNA binding domain, though
less efficiently than a LexA fusion to E2 residues 1 toreduced activity in yeast (18% of WT). The lack of correla-
tion between mutations which inactivate transcriptional 216 (Fig. 1). Although this region of E2 does not appear
to resemble any known transcriptional activation domain,activation and BH consensus positions in region A1 of
E2 suggests that this motif is not critical. In this respect some of the most defective mutants (W130R, Y138F/H,
and W145R) affect bulky hydrophobic amino acids. Itthe BH motif within region A1 could be similar to a subdo-
main of the VP16 TAD. Mutations at BH consensus posi- does not appear that W130 and W145 fall within BH mo-
tifs as described in Fig. 2A. In addition, W145 is highlytions in the VP16 B subdomain (residues 457–490) do
not severely affect transcriptional activation (Regier et conserved in other papillomavirus E2 proteins (Giri and
Yaniv, 1988), but no evidence for a BH motif was foundal., 1993). In contrast, function of the VP16 A subdomain
(residues 410–456) is highly sensitive to nonconserva- in this region of human papillomavirus E2 ORFs. Further
evidence for the functional importance of the 134–216tive substitutions at BH consensus positions (Regier et
al., 1993). interval of E2 comes from a previous genetic study which
described a mutant of BPV-1 E2 (E2ts1) that is tempera-A second BH motif which spans E2 residues 87–107
appears to be analogous to VP16 A (Fig. 2A). Highly ture sensitive for transcriptional activation and episomal
growth in the context of the BPV-1 genome in mousedefective point mutations affecting three of four BH con-
sensus positions (F87S, W92R, and W99C) were identi- C127 cells (DiMaio and Settleman, 1988). This mutation
was constructed by insertion of Pro–Arg–Pro–Arg be-fied in the phenotypic screen (Fig. 2C). Of six mutations
isolated in this region of E2, three affected BH consensus tween S181 and T182. In the yeast phenotypic screen
we identified S181F, which is partially defective for tran-positions. The other three highly defective mutations in-
volved radical substitutions within the BH consensus mo- scriptional activation (Table 1).
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Gill, G., Pascal, E., Tseng, Z. H., and Tjian, R. (1994). A glutamine-The large E2 TAD likely interacts with several cellular
rich hydrophobic patch in transcriptional factor Sp1 contacts theproteins to activate transcription. Our data suggest that
dTAFll110 component of drosophila TFllD complex and mediates
it is composed of multiple interdependent domains. Rela- transcriptional activation. Proc. Natl. Acad. Sci. USA 91, 1891–1896.
tively little is known about proteins which interact with Gill, G., and Ptashne, M. (1987). Mutants of Gal4 protein altered in an
activation function. Cell 51, 121–126.the E2 transcriptional activation domain. It has been re-
Gill, G., Sadowski, I., and Ptashne, M. (1990). Mutations that increaseported that the region of E2 spanning residues 161 to
the activity of a transcriptional activator in yeast and mammalian282 enhances binding of TBP to the TATA sequence
cells. Proc. Natl. Acad. Sci. USA 87, 2127–2131.
(Steger et al., 1995). The VP16 TAD is known to physically Giri, I., and Yaniv, M. (1988). Structural and mutational analysis of E2
interact with several cellular factors, including basal tran- trans-activating proteins of papillomaviruses reveals three distinct
functional domains. EMBO J. 7, 2823–2829.scription factors (TBP, TFIIB), a TAF (dTAFII40), and a
Goodrich, J. A., Hoey, T., Thut, C. J., Admon, A., and Tjian, R. (1993).coactivator (PC4, see discussion) (Ge and Roeder, 1994).
Drosophila TAFII40 interacts with both a VP16 activation domain andThe E2 mutants described in this study should prove
the basal transcription factor TFIID. Cell 75, 519–530.
useful to decipher the physiological relevance of what Grossel, M. G., Prakash, S. S., Barsoum, J., and Androphy, E. J. (1996).
could prove to be multiple E2 protein–protein interac- The BPV-1 E2 DNA contact helix cysteine is required for transcrip-
tional activation but not replication in mammalian cells. Virology 217,tions.
301–310.
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